<!DOCTYPE html><html><head><link href='https://fonts.googleapis.com/css?family=Spectral' rel='stylesheet'><style>body {    font-family: 'Spectral';font-size: 14px;}</style></head><body><b>Search Term: </b>(ageing OR aging) AND (mTOR OR senescence OR lysosome OR "cellular reprogramming")<br><b>Date run: </b>2020/01/25<br><br><h2>PubMed Articles</h2> <br><b><a href="https://ncbi.nlm.nih.gov/pubmed/31772305">Microglial regional heterogeneity and its role in the brain.</a></b><br><b>Journal:</b> Mol. Psychiatry<br><b>Two-year IF:</b> 11.46<br><br><b><a href="https://ncbi.nlm.nih.gov/pubmed/31740756">MicroRNA mediators of early life stress vulnerability to depression and suicidal behavior.</a></b><br><b>Journal:</b> Mol. Psychiatry<br><b>Two-year IF:</b> 11.46<br><br><b><a href="https://ncbi.nlm.nih.gov/pubmed/31601718">A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF/M-CSFR signalling in monocyte-derived alveolar macrophages.</a></b><br><b>Journal:</b> Eur. Respir. J.<br><b>Two-year IF:</b> 7.80<br><br><b><a href="https://alexmakijokela.github.io/202001251607_ageing.html#pubmed">More Results...</a></b><br><br><h2>Companies</h2> <br><b><a href="https://alexmakijokela.github.io/202001251607_ageing.html#companies">More Results...</a></b><br><br><h2>Patents</h2> <br><b><a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=9&p=1&f=G&l=50&d=PTXT&S1=((ageing+OR+aging)+AND+(((mTOR+OR+senescence)+OR+lysosome)+OR+%22cellular+reprogramming%22))&OS=+(ageing+OR+aging)+AND+(mTOR+OR+senescence+OR+lysosome+OR+"cellular+reprogramming")&RS=((ageing+OR+aging)+AND+(((mTOR+OR+senescence)+OR+lysosome)+OR+"cellular+reprogramming"))">Methods for increasing intracellular activity of Hsp70</a></b><br><b>Patent date:</b> January 14, 2020<br><br><b><a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=24&p=1&f=G&l=50&d=PTXT&S1=((ageing+OR+aging)+AND+(((mTOR+OR+senescence)+OR+lysosome)+OR+%22cellular+reprogramming%22))&OS=+(ageing+OR+aging)+AND+(mTOR+OR+senescence+OR+lysosome+OR+"cellular+reprogramming")&RS=((ageing+OR+aging)+AND+(((mTOR+OR+senescence)+OR+lysosome)+OR+"cellular+reprogramming"))">Blood plasma fractions as a treatment for aging-associated cognitive disorders</a></b><br><b>Patent date:</b> January 7, 2020<br><br><b><a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=40&p=1&f=G&l=50&d=PTXT&S1=((ageing+OR+aging)+AND+(((mTOR+OR+senescence)+OR+lysosome)+OR+%22cellular+reprogramming%22))&OS=+(ageing+OR+aging)+AND+(mTOR+OR+senescence+OR+lysosome+OR+"cellular+reprogramming")&RS=((ageing+OR+aging)+AND+(((mTOR+OR+senescence)+OR+lysosome)+OR+"cellular+reprogramming"))">Removing senescent cells from a mixed cell population or tissue using a phosphoinositide 3-kinase (PI3K) inhibitor</a></b><br><b>Patent date:</b> December 31, 2019<br><br><b><a href="https://alexmakijokela.github.io/202001251607_ageing.html#patents">More Results...</a></b><br><br><br><b><a href="https://alexmakijokela.github.io/202001251607_ageing.html">Link to Full Search Results</a></b><br></body></html>